5/29
05:45 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) was downgraded by analysts at Maxim Group from a "strong-buy" rating to a "hold" rating.
Low
Report
BIOLASE, Inc. (NASDAQ: BIOL) was downgraded by analysts at Maxim Group from a "strong-buy" rating to a "hold" rating.
5/14
11:45 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $0.40 price target on the stock.
Low
Report
BIOLASE, Inc. (NASDAQ: BIOL) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $0.40 price target on the stock.
5/14
11:45 am
biol
BIOLASE, Inc. (NASDAQ: BIOL) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $0.40 price target on the stock.
Low
Report
BIOLASE, Inc. (NASDAQ: BIOL) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $0.40 price target on the stock.
5/14
11:41 am
biol
Rating for BIOL
Low
Report
Rating for BIOL
5/14
11:41 am
biol
Rating for BIOL
Low
Report
Rating for BIOL
4/1
05:38 am
biol
Rating for BIOL
Medium
Report
Rating for BIOL
3/22
01:37 pm
biol
Rating for BIOL
Medium
Report
Rating for BIOL
3/22
01:37 pm
biol
Rating for BIOL
Medium
Report
Rating for BIOL